Zobrazeno 1 - 5
of 5
pro vyhledávání: '"X.L. Firvida"'
EP1.16-01 A Spanish Initiative to Know the Unmet Needs of Women with Lung Cancer: 'Circulos Program'
Autor:
F. Vazquez Rivera, J. De Castro Carpeno, Margarita Majem, Nuria Viñolas, X.L. Firvida, R. Garcia Campelo, M. Lázaro, Dolores Isla, Silvia Vazquez
Publikováno v:
Journal of Thoracic Oncology. 14:S1064
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cristina Peña, J.E. Castro, Martín Lázaro, J. Casal Rubio, X.L. Firvida, M. Vieito Villar, B. Taboada, F. Barón, Silvia Vazquez, E. Hernandez
Publikováno v:
Annals of Oncology. 23:ix395-ix396
Background CChRT is recommended as the evidence-based approach for the management of patients (p) with locally advanced stage III NSCLC and a good performance status, although a clearly superior regimen has not been identified. The aim of our study w
Autor:
M. Medina, A. Gomez, P. Calvo, M. Carmona, X.L. Firvida, S. Varela, M.C. López, O. Fernández, N. Garcia, J. Casal, B. Campos, E. Hernández, B. Taboada, F. Vázquez, M. Lázaro, U. Anido, M. Caeiro, C. Grande, Cristina Peña
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 18:S262
Autor:
M. Dietel, M. von Laffert, A. Lavole, S.I. Ou, D. Li, P. Lohneis, A. Van Baardwijk, Jeffrey W. Clark, Yuankai Shi, S. Temraz, Marileila Varella-Garcia, N.S. Turhal, L. Zhao, J.X. Zhou, Laurent Greillier, Faysal Dane, Savas Topuk, Tony Mok, H. Pang, Julia Bonastre, N. Yamamoto, Stephen L. Graziano, M. Wolf, K. Fujimoto-Ouchi, Martin H. Falk, S. Niho, M. Han, A. Grigorescu, R. Lamy, Victoria Soldatenkova, Miyako Satouchi, Dirk De Ruysscher, D.R. Camidge, M. Oellers, Rinus Wanders, G. Nalbantov, Pierre Hainaut, Paul Baas, H. Kreipe, W. El-Sadda, S. Kudoh, X.L. Firvida, M. Lazaro, Yang Sun, Miklos Pless, D. Lenze, Perran Fulden Yumuk, Katsuyuki Hotta, Carla Visseren-Grul, K. Tsujino, T. Tamura, L. Tye, Yoshihiro Nishimura, W. Slichenmyer, K. Kubota, Vanessa Rousseau, Jeffrey A. Engelman, T. Orlowski, D. Smith, R.N. Murray, Yang Yao, X. Hu, X. Wang, R. Vandendries, M. El-Ashry, R. Varea, N. Kuriyama, J. Kiemle-Kallee, P. He, C. Le Pechoux, Philippe Lambin, I.A. Koroleva, Bart Reymen, A. Vergnenegre, A. Reuss, J.E. Castro, Hirohisa Yoshizawa, W-T. Lim, R. Penzel, J.P. Pignon, H.H. Strøm, G. Karaüç, Kevin Jasas, J.G. Kutyreva, M.V. Kopp, Y. Liu, N. Chouaki, J.R. Fischer, C. Chouaid, M. Das, Ariane Dunant, E. Hernández, W. Jochum, P. Schnabel, S.E. Boeru, Cem Parlak, T. Korse, K. McKee, Kazuhiko Nakagawa, W. Van Elmpt, Lesley Seymour, Yasutaka Chiba, A.D. Vincent, M. Perol, Kwan Park, A. He, I. Borget, L.V. Shaplygin, I. Petersen, Janneke P.C. Grutters, K. Wilner, X. Ma, R. von Moos, J. Casal Rubio, K. Furugaki, H. Sharifi, P. Gopalakrishna, R. Sekiguchi, G. Zalcman, Z. Akgün Cetinkaya, S. Atagi, V. Lee, W. Dyszkiewicz, J. Belderbos, S. Agarwal, Colum Smith, M. Credi, T. Iwai, R. Ramlau, B.L.T. Ramaekers, G. Bootsma, Shaoming Wang, Wei-Xiang Qi, A. Spira, Béranger Lueza, J. Jiang, P. Schirmacher, Ozgur Ozyilkan, M. van den Heuvel, N. Helbekkmo, D. Betticher, Y. Moriya, I. Abdel Halim, X. Han, Jianxing He, I. Turtoi, X. Gu, M. Meister, F. Barón, M. Chabowski, B. Taboada, T. Akimoto, Michael Thomas, N. Nogami, Martin Filipits, W. Uyterlinde, N. Pourel, Yasuhito Fujisaka, Benjamin Lacas, E.H. Tan, I. Martel-Lafay, Michael Hummel, Toyoaki Hida, S. Barriga, Katsuyuki Kiura, U. Aasebø, Lin Gui, Anthony J. Iafrate, Andrew Maksymiuk, S. Sundstrøm, I. Sekine, Denis Soulières, Y. Ohe, Sotaro Enatsu, M. Zhao, H. Yang, H. Nokihara, S. Chabaud, Sarayut Lucien Geater, R. Bremnes, M. Vieito Villar, M.A. Joore, Charles Butts, C. Pena, R. Gervais, D. Perol, N. Sunnetci, K. Nihei, A.H. Loos, Niels Reinmuth, Glenwood D. Goss, M. Öllers, M. Salzberg, Stefan Scherer, A-M.C. Dingemans, E. Berg, N.N. Zhang, C. Droege, Erkan Topkan, Q. Deng, Alice T. Shaw, Sumitra Thongprasert, Reinhard Büttner, J. Li, C. Reynolds, J. Sonke, P. Fournel, Audrey Mauguen, Peter M. Ellis, F. Lin, N. Ianotti, S. Vazquez, S.V. Kozlov, M.E. Popova, L. Ma, I. Alsan Cetin, L. Zheng, M. Tsao, Jean-Yves Douillard, Y. Ito, P. Stephenson, Zan Shen, D. Arpin, A. Madroszyk, Beste M. Atasoy, M. Sumi
Publikováno v:
Annals of Oncology. 23:ix389
Background Chromosomal rearrangements in the receptor tyrosine kinase (RTK) ROS1 define a new molecular subset of NSCLC. ALK inhibitors can inhibit ROS1 kinase activity in cell lines. We examined the efficacy and safety of crizotinib, a small molecul